key: cord-0794700-j5w4xrr6 authors: Stjärne Aspelund, Anna; Hammarström, Helena; Inghammar, Malin; Larsson, Hillevi; Hansson, Lennart; Christensson, Bertil; Påhlman, Lisa I. title: Heparin‐binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients date: 2017-09-15 journal: Am J Transplant DOI: 10.1111/ajt.14458 sha: a2c2196aecd2142d5881124b7cd8ff252581c784 doc_id: 794700 cord_uid: j5w4xrr6 Pulmonary infection is a common complication after lung transplantation, and early detection is crucial for outcome. However, the condition can be clinically difficult to diagnose and to distinguish from rejection. The aim of this prospective study was to evaluate heparin‐binding protein (HBP), lysozyme, and the cytokines interleukin (IL)‐1β, IL‐6, IL‐8, IL‐10 and tumor necrosis factor (TNF) in bronchoalveolar lavage fluid (BALF) as potential biomarkers for pulmonary infection in lung‐transplanted patients. One hundred thirteen BALF samples from 29 lung transplant recipients were collected at routine scheduled bronchoscopies at 3 and 6 months, or on clinical indication. Samples were classified into no, possible, probable, or definite infection at the time of sampling. Rejection was defined by biopsy results. HBP, lysozyme, and cytokines were analyzed in BALF and correlated to likelihood of infection and rejection. All biomarkers were significantly increased in BALF during infection, whereas patients with rejection presented low levels that were comparable to noninfection samples. HBP, IL‐1β, and IL‐8 were the best diagnostic markers of infection with area under the receiver‐operating characteristic curve values of 0.88, 0.91, and 0.90, respectively. In conclusion, HBP, IL‐1β, and IL‐8 could be useful diagnostic markers of pulmonary infection in lung‐transplanted patients. can therefore be difficult to distinguish clinically. However, Lntx patients may lack classical signs of infection due to heavy immunosuppression, and rejection may be asymptomatic. In addition, there are possible links between infection and the development of rejection. 4 For example, viral pneumonia has been associated with chronic lung allograft dysfunction and graft loss. 5 Antimicrobial peptides in respiratory secretions play an important role as a first line of defence against infections. 7 Lysozyme is the most abundant airway antimicrobial peptide, and is secreted primarily by neutrophils and sub-mucosal glands. 8 Heparin-binding protein (HBP) was initially recognized for its broad antimicrobial activity, but is now known to be a multifunctional inflammatory mediator that induces vascular leakage and acts as a chemoattractant and activator of monocytes. 9, 10 The protein is stored in secretory and azurophilic granules of neutrophils, and is rapidly released upon cell activation. 11 Plasma HBP has been described as a promising biomarker for severe sepsis and septic shock, 12 and elevated HBP levels have also been shown in cerebrospinal fluid during bacterial meningitis 13 and in urine during urinary tract infections. 14 Neither HBP nor lysozyme has previously been evaluated in BALF of Lntx patients. In this study, we quantified the two proteins together with the pro-inflammatory cytokines interleukin (IL)-1β, IL-6, IL-8 and TNF, and anti-inflammatory IL-10 in BALF collected during the first year after transplantation. The primary aim was to evaluate HBP and lysozyme as potential biomarkers for infection, and to determine their ability to discriminate infection from rejection in lung transplant recipients. This prospective cohort study was conducted at Skåne University Hospital, one of two centers in Sweden that performs Lntx. Adult patients accepted for Lntx during the study period from October 2012 to December 2014 were eligible for inclusion. Patients younger than 18 years of age and patients with postoperative follow-up at other sites were excluded. All study participants were followed for a maximum of 1 year after transplantation. Written informed consent was obtained from all study patients. The study was approved by the regional ethics committee (Reg nr 433-08) and performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments. Standard protocol for immune suppression included induction therapy with ATG (anti-thymocyte globulin), followed by tacrolimus or cyclosporine, mycophenolate mofetil, and steroids. All Lntx recipients were treated with cytomegalovirus and fungal prophylaxis for 3-6 months. BALF samples were collected at routine scheduled bronchoscopies at 3 and 6 months after Lntx or at diagnostic bronchoscopies performed in response to clinical symptoms. A minimal interval of 7 days was allowed between BALs to be included as a new sample in the study. BAL procedure followed a standardized protocol. Study samples for analyses of HBP, lysozyme, and cytokines were obtained after installation of 20 mL phosphate-buffered saline (PBS), where the initial 10 mL of BALF was discharged after which a study sample of 10 mL was collected. Portions of 20 mL of PBS were then instilled to collect BALF according to a standard protocol for bacterial, fungal, and cytological analyses. BALF was sent to the Skåne University TBBs was semi-quantitatively reported as no, mild, or acute/abundant inflammation. The likelihood of pulmonary infection at the time of BALF sampling was independently, and blinded to the results of the biomarkers, To adjust for dilution of BALF in estimating the biomarker concen- Chi-square, rank sum, Kruskal-Wallis, and Mann-Whitney U tests were Using logistic regression, we calculated odds ratios (ORs) for infection (dichotomized into definite and probable vs no or possible infection and rejection) for each biomarker. We used generalized estimating equation (GEE) models to account for the possibility of dependency due to multiple observations from the same patient. The different biomarkers were first analyzed in univariable models and secondly in models adjusted for time after Lntx. All statistical tests were two-sided, and 95% confidence intervals (CIs) that In total, 39 patients were transplanted during the study period. Five patients were not eligible for inclusion due to follow-up at another center, and one patient declined participation. Consequently, 33 patients were included in the study. Four participants died shortly after transplantation, before any study samples were collected, leaving 29 lung transplant recipients prospectively followed in this study. The patients, 12 women and 17 men, had a median age of 56 years, 86% underwent double lung transplantation, and cystic fibrosis was the most common underlying disease. For details on patient characteristics, see Table 2 . Patients were assessed for infection at the time of BAL as described in Table 1 Bacterial growth was detected in 54 BALF samples (48%). Pseudomonas aeruginosa was the most commonly isolated bacterial species (12%), followed by Escherichia coli (9% At an HBP cut-off value of 150 ng/mL, sensitivity was 75% and specificity was 92% for the detection of infection; positive predictive value (PPV) and negative predictive value (NPV) were 92% and 76%, respectively. IL-1β and IL-8 performed similar to HBP, whereas lysozyme showed poor sensitivity and specificity (Table 3) . In this prospective study on lung transplant recipients comparing different biomarkers for prediction of infection, we found that HBP, Similar to HBP and lysozyme, all cytokines increased with the likelihood of infection, mirroring increased inflammation. IL-10 has anti-inflammatory properties but showed the same pattern as the pro-inflammatory cytokines in this study. IL-10 is believed to play an important role in balancing the inflammatory response in order to limit host tissue damage. 19 For example, compared to wild-type mice, IL-10-deficient mice demonstrate more efficient bacterial clearance but higher mortality and increased neutrophil recruitment to the lung in response to Streptococcus pneumoniae infection, 20 which underscores the regulatory role of IL-10 during infection. It could therefore be speculated that IL-10 increases simultaneously with pro-inflammatory cytokines in order to avoid excessive inflammation that would be harmful to the host. To correct for dilution factors of BALF, we used the urea method as In this study, we found no significant differences in levels between rejection and noninfection for any of the biomarkers. Contrary to our results, Patella et al have demonstrated increased levels of IL-10 during rejection compared to no rejection. 22 One possible reason for this discrepancy is that rejection is defined differently in the two studies. Here, we identify rejection with TBB to ensure correct diagnosis. All tested biomarkers have in common that they indicate neutrophil-dominated inflammation. In contrast, rejection is primarily a T cell-driven process, 23 The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: primary Diagnostic Indications for Transplant Long term complications following 54 consecutive lung transplants Therapeutic approach to respiratory infections in lung transplantation Association of TNF-alpha, TGF-beta1, IL-10, IL-6, and IFN-gamma gene polymorphism with acute rejection and infection in lung transplant recipients Graft loss and CLAD-onset is hastened by viral pneumonia after lung transplantation Multidrug-resistant bacteria in solid organ transplant recipients Antimicrobial peptides and innate lung defenses: role in infectious and noninfectious lung diseases and therapeutic applications Antimicrobial proteins and peptides in human lung diseases: a friend and foe partnership with host proteases Roles of heparin-binding protein in bacterial infections Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability Secretion of heparin-binding protein from human neutrophils is determined by its localization in azurophilic granules and secretory vesicles Heparin-binding protein measurement improves the prediction of severe infection with organ dysfunction in the emergency department Heparin-binding protein: a diagnostic marker of acute bacterial meningitis Heparin-binding protein: a diagnostic biomarker of urinary tract infection in adults Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients Description of an automated method for urea nitrogen determination in bronchoalveolar lavage fluid (BALF) of neonates and infants Inflammatory cells and activation markers in BAL during acute rejection and infection in lung transplant recipients: a prospective, longitudinal study Opposing roles of IL-10 in acute bacterial infection Interleukin-10 plays a key role in the modulation of neutrophils recruitment and lung inflammation during infection by Streptococcus pneumoniae Diagnostic accuracy of pulmonary host inflammatory mediators in the exclusion of ventilatoracquired pneumonia Role of cytokine profile in the differential diagnosis between acute lung rejection and pulmonary infections after lung transplantation † Biomarkers of pulmonary rejection Early and late infections in lung transplantation patients Heparin-binding protein, lysozyme, and inflammatory cytokines in bronchoalveolar lavage fluid as diagnostic tools for pulmonary infection in lung transplanted patients The authors of this manuscript have conflicts of interest to disclose as described by the American Journal of Transplantation. One of the authors (BC) of this manuscript is listed as co-inventor on a patent on the use of HBP as a diagnostic tool in sepsis filed by Hansa Medical AB. The other authors have no conflicts of interest to disclose.